RVINE, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) — Laguna Tech USA, a privately-held medical technology company dedicated to innovations in structural heart solutions to broaden useability and applicability for patients, today announced that a record number five patients were successfully treated at a single center on the same day with the ZETA Balloon Expandable Aortic Valve System to treat aortic valve disease. In all cases, patients achieved complete resolution of aortic disease with no residual stenosis or regurgitation immediately following the procedure, and all patients were discharged within 24-48 hours of the procedure. The high volume of procedures was made possible due to the versatility and flexibility of the novel design of the ZETA system, which provides greater ease of implantability for a broader patient population than currently approved valve systems. All five implants were accomplished on the same day at the Instituto Nacional de Torax in Santiago, Chile within the ongoing feasibility trial for the ZETA system.
The ZETA system is a novel balloon-expandable transcatheter valve with six expanding arms and a low profile covered delivery system.
Dr. Christian Dauvergne, Chief of Interventional Cardiology, Instituto Nacional de Torax, added, “Our ability to successfully implant the ZETA Aortic Valve in five patients with complex, diverse clinical profiles on a single day was due to the very simple and efficient design characterized by a low profile and straightforward transcatheter system, which allows for simple, advantageous placement in the heart. I look forward to the continued development of the ZETA device to explore the potential of this breakthrough technology to treat more patients with aortic regurgitation with unmet needs.”
